Published in Med Care on November 01, 2001
Association of incident dementia with hospitalizations. JAMA (2012) 2.74
Diagnosis-based risk adjustment for medicare prescription drug plan payments. Health Care Financ Rev (2007) 2.01
Medicaid expenditures on psychotropic medications for maltreated children: a study of 36 States. Psychiatr Serv (2014) 1.99
Applying a risk-adjustment framework to primary care: can we improve on existing measures? Ann Fam Med (2004) 1.47
Risk segmentation related to the offering of a consumer-directed health plan: a case study of Humana Inc. Health Serv Res (2004) 1.36
The association of comorbidities, utilization and costs for patients identified with low back pain. BMC Musculoskelet Disord (2006) 1.21
Comorbidity risk-adjustment strategies are comparable among persons with hip fracture. J Clin Epidemiol (2008) 1.16
The impact of concordant and discordant conditions on the quality of care for hyperlipidemia. J Gen Intern Med (2008) 1.07
Case selection for a Medicaid chronic care management program. Health Care Financ Rev (2008) 1.03
Case-mix adjusting performance measures in a veteran population: pharmacy- and diagnosis-based approaches. Health Serv Res (2003) 0.99
Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries. J Gen Intern Med (2013) 0.98
Association between race, depression, and antiretroviral therapy adherence in a low-income population with HIV infection. J Gen Intern Med (2012) 0.97
The effect of substance abuse treatment on Medicaid expenditures among general assistance welfare clients in Washington state. Milbank Q (2006) 0.96
Changes in per member per month expenditures after implementation of Florida's Medicaid reform demonstration. Health Serv Res (2011) 0.94
Medicaid expenditures on psychotropic medications for children in the child welfare system. J Child Adolesc Psychopharmacol (2012) 0.94
The influence of socio-economic status and multimorbidity patterns on healthcare costs: a six-year follow-up under a universal healthcare system. Int J Equity Health (2013) 0.91
Using risk adjustment approaches in child welfare performance measurement: Applications and insights from health and mental health settings. Child Youth Serv Rev (2010) 0.89
Comparison of Rx-defined morbidity groups and diagnosis- based risk adjusters for predicting healthcare costs in Taiwan. BMC Health Serv Res (2010) 0.86
Health Care Use and Spending for Medicaid Enrollees in Federally Qualified Health Centers Versus Other Primary Care Settings. Am J Public Health (2016) 0.84
A new model of well-child care: implications for resource costs and dissemination. Perm J (2011) 0.83
Psychotropic drug use among preschool children in the Medicaid program from 36 states. Am J Public Health (2015) 0.83
Improving the prediction model used in risk equalization: cost and diagnostic information from multiple prior years. Eur J Health Econ (2014) 0.81
A randomized controlled trial of intensive care management for disabled Medicaid beneficiaries with high health care costs. Health Serv Res (2014) 0.81
Comparative performance of comorbidity indices in predicting health care-related behaviors and outcomes among Medicaid enrollees with type 2 diabetes. Popul Health Manag (2012) 0.80
Disease identification based on ambulatory drugs dispensation and in-hospital ICD-10 diagnoses: a comparison. BMC Health Serv Res (2013) 0.79
The predictability of claim-data-based comorbidity-adjusted models could be improved by using medication data. BMC Med Inform Decis Mak (2013) 0.78
Risk Adjustment Tools for Learning Health Systems: A Comparison of DxCG and CMS-HCC V21. Health Serv Res (2016) 0.77
Racial/ethnic differences in Medicaid expenditures on psychotropic medications among maltreated children. Child Abuse Negl (2014) 0.75
A Review on Methods of Risk Adjustment and their Use in Integrated Healthcare Systems. Int J Integr Care (2016) 0.75
Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology (1997) 9.70
Effects of offering advance directives on medical treatments and costs. Ann Intern Med (1992) 5.80
Patient preferences for colorectal cancer screening. J Fam Pract (1997) 4.55
A consumer-choice health plan for the 1990s. Universal health insurance in a system designed to promote quality and economy (1). N Engl J Med (1989) 2.46
Attitudes of seriously ill patients toward treatment that involves high costs and burdens on others. J Clin Ethics (1994) 2.25
Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis. Arthritis Rheum (1995) 2.09
Circumcision reevaluated. West J Med (1989) 2.00
The Community Medical Alliance: an integrated system of care in Greater Boston for people with severe disability and AIDS. Manag Care Q (1996) 1.81
Universal neonatal hepatitis B immunization--are we jumping on the bandwagon too early? J Fam Pract (1993) 1.80
A consumer-choice health plan for the 1990s. Universal health insurance in a system designed to promote quality and economy (2). N Engl J Med (1989) 1.67
The Quality of Well-Being Scale: critical similarities and differences with SF-36. Int J Qual Health Care (1998) 1.46
Ultrasound-guided liver biopsy for parenchymal liver disease: an economic analysis. Dig Dis Sci (1998) 1.41
Preventive medicine and public health: advances in prenatal screening. West J Med (1990) 1.40
Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest (1992) 1.39
Judging the guidelines for colorectal cancer screening. Am Fam Physician (1997) 1.37
Explaining the decline in health insurance coverage, 1979-1995. Health Aff (Millwood) (1999) 1.37
Universal health insurance through incentives reform. JAMA (1991) 1.30
Blood pressure change and survival after age 75. Hypertension (1993) 1.27
Resistance of muscle to tumor metastases: a role for a3 adenosine receptor agonists. Neoplasia (2001) 1.25
Prevalence, expenditures, utilization, and payment for persons with MS in insured populations. Neurology (2002) 1.19
The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease. Cell Immunol (2009) 1.18
Induction of an antiinflammatory effect and prevention of cartilage damage in rat knee osteoarthritis by CF101 treatment. Arthritis Rheum (2009) 1.18
Who enrolled in a state program for the uninsured: was there adverse selection? Med Care (1993) 1.17
Health care utilization and cost among children with asthma who were enrolled in a health maintenance organization. Pediatrics (1997) 1.17
Health care utilization and cost in children with asthma and selected comorbidities. J Asthma (2001) 1.16
The A3 adenosine receptor agonist CF102 induces apoptosis of hepatocellular carcinoma via de-regulation of the Wnt and NF-kappaB signal transduction pathways. Int J Oncol (2008) 1.12
Preoperative drug dispensing as predictor of surgical site infection. Emerg Infect Dis (2001) 1.11
Factors associated with paradoxical survival at higher blood pressures in the very old. Am J Epidemiol (1991) 1.11
Muscle cells produce a low molecular weight factor with anti-cancer activity. Clin Exp Metastasis (1996) 1.08
Tolerability, pharmacokinetics and concentration-dependent hemodynamic effects of oral CF101, an A3 adenosine receptor agonist, in healthy young men. Int J Clin Pharmacol Ther (2004) 1.08
Anti-tyrosinase antibodies in malignant melanoma. Cancer Immunol Immunother (1996) 1.00
Incremental cost-effectiveness analysis: the optimal strategy depends on the strategy set. J Clin Epidemiol (1999) 1.00
Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101. Br J Cancer (2003) 0.99
Involvement of Wnt signaling pathway in murine medulloblastoma induced by human neurotropic JC virus. Oncogene (2001) 0.99
CF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver. J Cell Physiol (2011) 0.99
The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-kappaB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats. Biochem Pharmacol (2008) 0.99
Computer-assisted assessment of family physicians' knowledge about cancer screening guidelines. West J Med (1985) 0.98
Estimating county percentages of people without health insurance. Inquiry (1991) 0.97
Phagocytotic activity of monocytes from diabetic patients. Diabetes Care (1989) 0.97
IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis. Clin Exp Rheumatol (2006) 0.95
Ascertaining dementia by expert panel in epidemiologic studies of nursing home residents. Ann Epidemiol (1996) 0.95
Clustering of atherogenic behaviors in coffee drinkers. Am J Public Health (1990) 0.94
A3 adenosine receptor: pharmacology and role in disease. Handb Exp Pharmacol (2009) 0.93
Treatment of plaque-type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial. J Eur Acad Dermatol Venereol (2011) 0.93
Melanoma-associated hypopigmentation: where are the antibodies? Am J Clin Oncol (1996) 0.91
Satellitism of platelets to monocytes in a patient with hypogammaglobulinaemia. Scand J Haematol (1978) 0.91
Epidemiological issues in perinatal outcomes research. Paediatr Perinat Epidemiol (1999) 0.90
Do cost-effectiveness analyses cause you dyspepsia? J Fam Pract (1997) 0.89
Tyrosinase as an autoantigen in patients with vitiligo. Clin Exp Immunol (1996) 0.89
Paradoxical survival of elderly men with high blood pressure. BMJ (1989) 0.89
Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor. J Cell Physiol (2001) 0.88
At-risk drinking among patients making routine primary care visits. Prev Med (2000) 0.88
Oral administration of muscle derived small molecules inhibits tumor spread while promoting normal cell growth in mice. Clin Exp Metastasis (1999) 0.87
Vitiligo- and melanoma-associated hypopigmentation: a similar appearance but a different mechanism. Cancer Immunol Immunother (1994) 0.87
Circumcision. West J Med (1989) 0.86
Psychoactive drug use by young and future physicians. J Health Soc Behav (1984) 0.85
Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression. Arthritis Rheum (1998) 0.84
Interleukin-2 and ovarian hyperstimulation syndrome: a pilot study. Hum Reprod (1995) 0.84
Antigens and antibodies in malignant melanoma. Tumour Biol (1994) 0.84
Intramitonchondrial crystalline inclusions in metastatic hypernephroma of the liver. Biomedicine (1974) 0.83
Acid-base balance and plasma composition in the aestivating lungfish (Protopterus). Am J Physiol (1977) 0.83
SEM observations on the mechanism of platelet release from megakaryocytes. Thromb Haemost (1979) 0.83
Controlling blood glucose levels in patients with type 2 diabetes mellitus. An evidence-based policy statement by the American Academy of Family Physicians and American Diabetes Association. J Fam Pract (2000) 0.82
Assessing the impact of migraine on health-related quality of life: An additional use of the quality of well-being scale-self-administered. Headache (2000) 0.81
Intravitreal ceftazidime in a rabbit model: dose- and time-dependent toxicity and pharmacokinetic analysis. J Ocul Pharmacol (1987) 0.81
Calm before the storm: expected increase in the number of uninsured Americans. Health Aff (Millwood) (2001) 0.81
Paroxysmal cold hemoglobinuria. Transmission and scanning electron microscopy features of erythrocytes. Am J Clin Pathol (1975) 0.80
A glossary of medical decision-making terms. Prim Care (1995) 0.80
Effect of dexamethasone on IL-1 and IL-3-LA release by unstimulated human mononuclear cells. Biomed Pharmacother (1990) 0.80
The surface ultrastructure of Gaucher cells. Am J Clin Pathol (1979) 0.80
Subconjunctival administration of ceftazidime in pigmented rabbit eyes. Arch Ophthalmol (1986) 0.80
Growth of human basophil lines derived from chronic myelocytic leukaemia cells in vitro: ultrastructure and X-ray microanalysis studies. Immunology (1985) 0.79
Shrinkage of melanoma metastases following high dose intravenous immunoglobulin treatment. Isr Med Assoc J (2001) 0.79
Scanning electron microscope observations on surface changes occurring in murine granulocytes and macrophages during maturation in soft agar cultures. Exp Hematol (1981) 0.79
Elemental X-ray microanalysis of mouse peritoneal and bone marrow derived cultured mast cells. Ann Allergy (1984) 0.79
Ultrastructural study of the erythropoietic events in human embryonic livers. Biol Neonate (1975) 0.79
The effect of surgically induced weight reduction on the serum levels of the cytokines: interleukin-3 and tumor necrosis factor. Obes Surg (1999) 0.79
Hematopoiesis in the embryonic mouse spleen. II. Alterations after phenylhydrazine administration to the mothers. Anat Rec (1975) 0.78
Ciprofloxacin affects pregnancy loss in CBA/JxDBA/2J mice possibly via elevation of interleukin-3 and granulocyte macrophage-colony stimulating factor production. Am J Reprod Immunol (2000) 0.78
Increased interleukin-1 and interleukin-3 like activity in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry (1995) 0.78
The clinical significance of antityrosinase antibodies in melanoma and related hypopigmentary lesions. Clin Rev Allergy Immunol (1998) 0.78
pH-induced platelet ultrastructural alterations. A possible mechanism for impaired platelet aggregation. Arch Surg (1979) 0.78
Interleukin-3 and pregnancy loss in antiphospholipid syndrome. Scand J Rheumatol Suppl (1998) 0.78
Clinical and ultrastructural observations in primary acquired sideroblastic anemia. Nouv Rev Fr Hematol (1976) 0.77
An economic analysis of norfloxacin prophylaxis against spontaneous bacterial peritonitis. J Hepatol (1997) 0.77
Accidental poisoning by warfarin-contaminated herbal tea. West J Med (1993) 0.77
The cyclical behavior of hospital utilization and staffing. Health Serv Res (1984) 0.77
Relationship between routine hematological parameters, serum IL-3, IL-6 and erythropoietin and mild anemia and degree of function in the elderly. Aging (Milano) (1998) 0.77
Gamma-globulin inhibits tumor spread in mice. Int Immunol (1999) 0.77
Malignant melanoma of the head and neck. Clinical and immunological considerations. Am J Clin Oncol (1996) 0.77
Synthesizing activity and ultrastructural findings of human blood cells after incubation with cis-platinum "in vitro". Biomedicine (1981) 0.77
The association of cervical spondylosis and multiple sclerosis. Surg Neurol (1992) 0.76
Chloramphenicol induced inhibition of platelet protein synthesis: in vitro and in vivo studies. Br J Haematol (1976) 0.76
Topographic changes of membrane receptors for wheat germ agglutinin during the cell cycle and their relation to cytolysis. Exp Cell Res (1980) 0.76
IL-3-LA production by mononuclear cells of patients with multiple sclerosis: effect of treatment with intravenous immunoglobulins. Immunol Invest (1995) 0.76
The effect of tetracycline administration on iron absorption in mice. Biomedicine (1981) 0.76
Advance directives, apples and oranges. Arch Intern Med (1995) 0.75
X-ray microanalysis of the fingernails in term and preterm infants. Pediatr Dermatol (1988) 0.75